(BN) Brookfield - Ratings and Ratios
Real Estate, Renewable Power, Infrastructure, Private Equity
BN EPS (Earnings per Share)
BN Revenue
Description: BN Brookfield
Brookfield Corporation is a diversified alternative asset manager with a strong presence in real estate, renewable power, infrastructure, and private equity. The firms investment strategy focuses on acquiring sizeable, premier assets across various geographies and asset classes, leveraging its expertise to drive growth and returns.
Key aspects of Brookfields investment approach include its ability to invest both its own capital and that of other investors, allowing it to take a flexible and opportunistic stance. The firm targets companies with underlying real assets, primarily in sectors such as industrial products, building materials, and energy, with a particular emphasis on mid-market companies that may be underperforming or in need of restructuring.
From a quantitative perspective, Brookfields financial performance can be evaluated using key performance indicators (KPIs) such as Assets Under Management (AUM), fee-bearing AUM, and carried interest. The firms AUM has historically grown through a combination of organic growth and strategic acquisitions, driving revenue and profitability. Additionally, metrics such as Return on Equity (RoE) and Return on Assets (RoA) can provide insight into the firms ability to generate returns on its investments.
Brookfields global presence, with operations in North America, Europe, Australia, and Asia-Pacific, provides a diversified revenue stream and exposure to various economic cycles. The firms investment horizon, typically ranging from 4 to 10 years, allows it to take a long-term view, focusing on fundamental value creation rather than short-term gains.
To further evaluate Brookfields investment potential, one could analyze its historical investment performance, including metrics such as internal rate of return (IRR) and cash-on-cash returns. Additionally, an assessment of the firms corporate governance, including the composition of its board and management team, can provide insight into its ability to execute on its investment strategy.
BN Stock Overview
| Market Cap in USD | 96,891m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 1983-12-30 |
BN Stock Ratings
| Growth Rating | 72.1% |
| Fundamental | 32.7% |
| Dividend Rating | 21.4% |
| Return 12m vs S&P 500 | 13.7% |
| Analyst Rating | 3.78 of 5 |
BN Dividends
| Dividend Yield 12m | 0.70% |
| Yield on Cost 5y | 1.66% |
| Annual Growth 5y | -3.73% |
| Payout Consistency | 95.7% |
| Payout Ratio | 32.3% |
BN Growth Ratios
| Growth Correlation 3m | 76.9% |
| Growth Correlation 12m | 60.9% |
| Growth Correlation 5y | 58% |
| CAGR 5y | 20.61% |
| CAGR/Max DD 5y | 0.49 |
| Sharpe Ratio 12m | 0.94 |
| Alpha | 9.85 |
| Beta | 1.474 |
| Volatility | 26.67% |
| Current Volume | 1754.2k |
| Average Volume 20d | 2507.5k |
| Stop Loss | 63.7 (-3.1%) |
| Signal | -0.59 |
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (841.0m TTM) > 0 and > 6% of Revenue (6% = 4.56b TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -0.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.40% (prev -18.30%; Δ 29.71pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 8.14b > Net Income 841.0m (YES >=105%, WARN >=100%) |
| Net Debt (236.93b) to EBITDA (22.56b) ratio: 10.50 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.53b) change vs 12m ago -0.14% (target <= -2.0% for YES) |
| Gross Margin 31.50% (prev 18.45%; Δ 13.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 15.16% (prev 19.09%; Δ -3.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.89 (EBITDA TTM 22.56b / Interest Expense TTM 17.21b) >= 6 (WARN >= 3) |
Altman Z'' 0.53
| (A) 0.02 = (Total Current Assets 74.61b - Total Current Liabilities 65.93b) / Total Assets 506.07b |
| (B) 0.03 = Retained Earnings (Balance) 16.45b / Total Assets 506.07b |
| (C) 0.03 = EBIT TTM 15.27b / Avg Total Assets 501.69b |
| (D) 0.11 = Book Value of Equity 36.72b / Total Liabilities 344.42b |
| Total Rating: 0.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 32.65
| 1. Piotroski 1.50pt = -3.50 |
| 2. FCF Yield -0.86% = -0.43 |
| 3. FCF Margin -4.51% = -1.69 |
| 4. Debt/Equity 6.79 = -2.50 |
| 5. Debt/Ebitda 14.03 = -2.50 |
| 6. ROIC - WACC 0.08% = 0.10 |
| 7. RoE 1.83% = 0.15 |
| 8. Rev. Trend -84.19% = -4.21 |
| 9. Rev. CAGR -8.97% = -1.50 |
| 10. EPS Trend 15.19% = 0.38 |
| 11. EPS CAGR -13.29% = -1.66 |
What is the price of BN shares?
Over the past week, the price has changed by +2.61%, over one month by -2.64%, over three months by +14.18% and over the past year by +33.80%.
Is Brookfield a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BN is around 70.64 USD . This means that BN is currently overvalued and has a potential downside of 7.4%.
Is BN a buy, sell or hold?
- Strong Buy: 2
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 72.9 | 10.8% |
| Analysts Target Price | 65.5 | -0.4% |
| ValueRay Target Price | 75.2 | 14.3% |
Last update: 2025-08-21 02:50
BN Fundamental Data Overview
CCE Cash And Equivalents = 13.70b USD (Cash only, last quarter)
P/E Trailing = 146.5227
P/E Forward = 19.3424
P/S = 1.2378
P/B = 2.2695
Beta = 2.242
Revenue TTM = 76.08b USD
EBIT TTM = 15.27b USD
EBITDA TTM = 22.56b USD
Long Term Debt = 250.63b USD (from longTermDebt, last quarter)
Short Term Debt = 65.93b USD (from totalCurrentLiabilities, last quarter)
Debt = 316.57b USD (Calculated: Short Term 65.93b + Long Term 250.63b)
Net Debt = 236.93b USD (from netDebt column, last quarter)
Enterprise Value = 399.75b USD (96.89b + Debt 316.57b - CCE 13.70b)
Interest Coverage Ratio = 0.89 (Ebit TTM 15.27b / Interest Expense TTM 17.21b)
FCF Yield = -0.86% (FCF TTM -3.43b / Enterprise Value 399.75b)
FCF Margin = -4.51% (FCF TTM -3.43b / Revenue TTM 76.08b)
Net Margin = 1.11% (Net Income TTM 841.0m / Revenue TTM 76.08b)
Gross Margin = 31.50% ((Revenue TTM 76.08b - Cost of Revenue TTM 52.11b) / Revenue TTM)
Tobins Q-Ratio = 10.89 (Enterprise Value 399.75b / Book Value Of Equity 36.72b)
Interest Expense / Debt = 1.44% (Interest Expense 4.55b / Debt 316.57b)
Taxrate = 34.64% (from yearly Income Tax Expense: 982.0m / 2.83b)
NOPAT = 9.98b (EBIT 15.27b * (1 - 34.64%))
Current Ratio = 1.13 (Total Current Assets 74.61b / Total Current Liabilities 65.93b)
Debt / Equity = 6.79 (Debt 316.57b / last Quarter total Stockholder Equity 46.60b)
Debt / EBITDA = 14.03 (Net Debt 236.93b / EBITDA 22.56b)
Debt / FCF = -92.29 (Debt 316.57b / FCF TTM -3.43b)
Total Stockholder Equity = 46.08b (last 4 quarters mean)
RoA = 0.17% (Net Income 841.0m, Total Assets 506.07b )
RoE = 1.83% (Net Income TTM 841.0m / Total Stockholder Equity 46.08b)
RoCE = 5.15% (Ebit 15.27b / (Equity 46.08b + L.T.Debt 250.63b))
RoIC = 3.48% (NOPAT 9.98b / Invested Capital 286.57b)
WACC = 3.40% (E(96.89b)/V(413.46b) * Re(11.45%)) + (D(316.57b)/V(413.46b) * Rd(1.44%) * (1-Tc(0.35)))
Shares Correlation 5-Years: -60.0 | Cagr: -1.46%
Discount Rate = 11.45% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -3.43b)
Revenue Correlation: -84.19 | Revenue CAGR: -8.97%
Rev Growth-of-Growth: -19.31
EPS Correlation: 15.19 | EPS CAGR: -13.29%
EPS Growth-of-Growth: 4.81
Additional Sources for BN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle